Drug delivery has become a critical differentiator in modern therapeutics, particularly as biologics, peptides, and advanced therapies increasingly move beyond the clinic and into patients' hands. Today, successful programs require more than a robust formulation — they depend on the seamless integration of delivery devices, human factors, analytical testing, manufacturing, and regulatory strategy.
This edition of the Outsourced Pharma Capabilities Update (OPCU) focuses on the specialized capabilities CDMOs bring to drug delivery and combination product development. From device selection and compatibility testing to sterile fill-finish, assembly, packaging, and commercialization, you'll gain insight into the expertise and technologies that help reduce development risk, accelerate timelines, and improve patient outcomes.
Recent Sessions Available On-Demand
Fill/Finish & Small Molecule – 4/21/2026 & 4/22/2026
Upcoming OPCU Topics & Times
Cell Therapy | 6/16/2026, AM Session
Cell Line Development | 6/16/2026, PM Session
Microbial Development & Manufacturing | 6/17/2026, AM Session
ADCs | 6/17/2026, PM Session
Access more on-demand OPCU recordings and upcoming sessions here.
